153 related articles for article (PubMed ID: 16820098)
1. Akt-and CREB-mediated prostate cancer cell proliferation inhibition by Nexrutine, a Phellodendron amurense extract.
Garcia GE; Nicole A; Bhaskaran S; Gupta A; Kyprianou N; Kumar AP
Neoplasia; 2006 Jun; 8(6):523-33. PubMed ID: 16820098
[TBL] [Abstract][Full Text] [Related]
2. Akt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract.
Kumar AP; Bhaskaran S; Ganapathy M; Crosby K; Davis MD; Kochunov P; Schoolfield J; Yeh IT; Troyer DA; Ghosh R
Clin Cancer Res; 2007 May; 13(9):2784-94. PubMed ID: 17473212
[TBL] [Abstract][Full Text] [Related]
3. Phellodendron amurense bark extract prevents progression of prostate tumors in transgenic adenocarcinoma of mouse prostate: potential for prostate cancer management.
Ghosh R; Graham H; Rivas P; Tan XJ; Crosby K; Bhaskaran S; Schoolfield J; Banu J; Fernandes G; Yeh IT; Kumar AP
Anticancer Res; 2010 Mar; 30(3):857-65. PubMed ID: 20393007
[TBL] [Abstract][Full Text] [Related]
4. Butanol fraction containing berberine or related compound from nexrutine inhibits NFkappaB signaling and induces apoptosis in prostate cancer cells.
Muralimanoharan SB; Kunnumakkara AB; Shylesh B; Kulkarni KH; Haiyan X; Ming H; Aggarwal BB; Rita G; Kumar AP
Prostate; 2009 Apr; 69(5):494-504. PubMed ID: 19107816
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Cox-2 by cyclic AMP response element binding protein in prostate cancer: potential role for nexrutine.
Ghosh R; Garcia GE; Crosby K; Inoue H; Thompson IM; Troyer DA; Kumar AP
Neoplasia; 2007 Nov; 9(11):893-9. PubMed ID: 18030357
[TBL] [Abstract][Full Text] [Related]
6. Tolerance of Phellodendron amurense bark extract (Nexrutine®) in patients with human prostate cancer.
Swanson GP; Jones WE; Ha CS; Jenkins CA; Kumar AP; Basler J
Phytother Res; 2015 Jan; 29(1):40-2. PubMed ID: 25205619
[TBL] [Abstract][Full Text] [Related]
7. Nexrutine inhibits survival and induces G1 cell cycle arrest, which is associated with apoptosis or autophagy depending on the breast cancer cell line.
Yan G; Lanza-Jacoby S; Wang C
Nutr Cancer; 2014; 66(3):506-16. PubMed ID: 24206214
[TBL] [Abstract][Full Text] [Related]
8. Palmatine inhibits growth and invasion in prostate cancer cell: Potential role for rpS6/NFκB/FLIP.
Hambright HG; Batth IS; Xie J; Ghosh R; Kumar AP
Mol Carcinog; 2015 Oct; 54(10):1227-34. PubMed ID: 25043857
[TBL] [Abstract][Full Text] [Related]
9. Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression.
Kochuparambil ST; Al-Husein B; Goc A; Soliman S; Somanath PR
J Pharmacol Exp Ther; 2011 Feb; 336(2):496-505. PubMed ID: 21059805
[TBL] [Abstract][Full Text] [Related]
10. Suppression of FAK by nexrutine inhibits gastric cancer progression.
Zhuang K; Guo H; Tang H; Yan Y; Yang Z; Wang Y
Life Sci; 2020 Sep; 257():118100. PubMed ID: 32679149
[TBL] [Abstract][Full Text] [Related]
11. Tirucallic acids are novel pleckstrin homology domain-dependent Akt inhibitors inducing apoptosis in prostate cancer cells.
Estrada AC; Syrovets T; Pitterle K; Lunov O; Büchele B; Schimana-Pfeifer J; Schmidt T; Morad SA; Simmet T
Mol Pharmacol; 2010 Mar; 77(3):378-87. PubMed ID: 20018812
[TBL] [Abstract][Full Text] [Related]
12. Nexrutine inhibits cancer cell growth as a consequence of mitochondrial damage and mitophagy.
Wu X; Zhou SM; Ding YL; Gong YP; Zeng W; Cui Y
Cell Physiol Biochem; 2015; 36(2):763-72. PubMed ID: 26021264
[TBL] [Abstract][Full Text] [Related]
13. Hirsutenone in Alnus extract inhibits akt activity and suppresses prostate cancer cell proliferation.
Kang S; Kim JE; Li Y; Jung SK; Song NR; Thimmegowda NR; Kim BY; Lee HJ; Bode AM; Dong Z; Lee KW
Mol Carcinog; 2015 Nov; 54(11):1354-62. PubMed ID: 25213146
[TBL] [Abstract][Full Text] [Related]
14. Sinodielide A exerts thermosensitizing effects and induces apoptosis and G2/M cell cycle arrest in DU145 human prostate cancer cells via the Ras/Raf/MAPK and PI3K/Akt signaling pathways.
Hatashita M; Taniguchi M; Baba K; Koshiba K; Sato T; Jujo Y; Suzuki R; Hayashi S
Int J Mol Med; 2014 Feb; 33(2):406-14. PubMed ID: 24285252
[TBL] [Abstract][Full Text] [Related]
15. Extracting the Benefit of Nexrutine
Hussain SS; Patel D; Ghosh R; Kumar AP
Curr Pharmacol Rep; 2015 Dec; 1(6):365-372. PubMed ID: 26539341
[TBL] [Abstract][Full Text] [Related]
16. Carnosic acid modulates Akt/IKK/NF-κB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells.
Kar S; Palit S; Ball WB; Das PK
Apoptosis; 2012 Jul; 17(7):735-47. PubMed ID: 22453599
[TBL] [Abstract][Full Text] [Related]
17. Dietary administration of berberine or Phellodendron amurense extract inhibits cell cycle progression and lung tumorigenesis.
James MA; Fu H; Liu Y; Chen DR; You M
Mol Carcinog; 2011 Jan; 50(1):1-7. PubMed ID: 21061266
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
Shankar S; Srivastava RK
Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
[TBL] [Abstract][Full Text] [Related]
19. Zyflamend reduces the expression of androgen receptor in a model of castrate-resistant prostate cancer.
Huang EC; Chen G; Baek SJ; McEntee MF; Collier JJ; Minkin S; Biggerstaff J; Whelan J
Nutr Cancer; 2011 Nov; 63(8):1287-96. PubMed ID: 21958043
[TBL] [Abstract][Full Text] [Related]
20. Combination of Nexrutine and docetaxel suppresses NFκB-mediated activation of c-FLIP.
Zhang Y; Li L; Wang J; Cheng W; Zhang J; Li X; Zhang Z; Gong J; Ghosh R; Kumar AP; Xie J
Mol Carcinog; 2017 Oct; 56(10):2200-2209. PubMed ID: 28485511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
